1.
The inhibitory effects and immunoregulatory activity of the fibrinolytic protein from Eupolyphaga sinensis Walker (EFP) in vivo on line H22 in mice
地鳖纤溶活性蛋白对H22荷瘤小鼠的抑瘤作用
2.
Cloning and Expression of Eupolyphaga sinensis Walker Fibrinolytic Protein cDNA in Pichia pastoris
地鳖虫纤溶活性蛋白cDNA序列克隆与毕赤酵母表达
3.
The Inhibitory Effect of the Protein of Eupolyphaga sinensis Walker(EES) on Human Tongue Cancer Cell Line Tea-8113 in vitro
地鳖虫活性蛋白对人舌癌细胞Tea-8113的抑制作用
4.
ANALYSIS OF SOLUBLE PROTEIN OF TRIONYX SINENSIS IN AEROMONAS FURUNCULOSIS
中华鳖气单胞菌疖疮病的可溶性蛋白质分析
5.
Purification and biochemical character of a fibrinolytic protein from Ampullarum crossean
福寿螺纤溶活性蛋白的纯化及性质研究
6.
Study on Extraction of Active Protein from Scolopendra subspinipes mutilans and its Fibrinolytic Activity
少棘蜈蚣活性蛋白提取及纤溶作用性质研究
7.
The Correlation of Fibrinolytic Activation, Lipoprotein(a) and Coronary Arterial Thrombosis;
纤溶活性、脂蛋白a与冠脉血栓形成的关系研究
8.
Study of the Adaptability to Low Protein Level Diets of Adult Chinese Soft-Shelled Turtle (Pelodisus Sinensis);
中华鳖成鳖对低蛋白饲料的适应性研究
9.
Detection of serum lipoprotein (α) level and fibrinolytic activity in patients with silent cerebral infarction
无症状性脑梗死患者血清脂蛋白(α)水平与纤溶活性检测
10.
Thrombin is an enzyme that catalyzes the conversion of the soluble plasma protein fibrinogen to the insoluble protein fibrin.
凝血酶能催化可溶性血浆纤维蛋白转化为不溶性的纤维蛋白。
11.
Study of the Adaptability to Dietary Protein Level in Chinese Soft-Shelled Turtle (Pelodiscus Sinensis);
中华鳖对饲料蛋白质水平适应性研究
12.
OBJECTIVE: To systematically review evidence of the association between fibrinolytic defects and recurrent miscarriage.
目的:系统地评价纤溶蛋白缺陷和习惯性流产俩者关联的证据。
13.
an inactive form of plasmin that occurs in plasma and is converted to plasmin by organic solvents.
血浆中血纤维蛋白溶酶不活跃的前体,能被有机溶剂转化成血纤维蛋白溶酶。
14.
fibrinolytic syndrome
纤维蛋白溶解综合征
15.
Differential proteomic analysis of liver plasma membrane in hepatic fibrosis rats treated with Fufang Biejia Ruangan
复方鳖甲软肝片治疗免疫性肝纤维化大鼠肝细胞质膜蛋白质组分的变化
16.
The inactive precursor to plasmin that is found in body fluids and blood plasma.
血纤维蛋白溶酶原血纤维蛋白溶酶不活跃的前体,常发现于体液和血浆中
17.
Study on the Levels of Thrombin Activable Fibrinolysis Inhibitor Active(TAFIa) in the Patients with Hemophilia
血友病患者凝血酶激活的纤维蛋白溶解抑制物活性(TAFIa)的检测及其临床意义
18.
Analysis of the Relationship Between Thrombin Activatable Fibrinolysis Inhibitor and Fibrinogen in Patients with Coronary Atherosclerotic Heart Disease
冠心病患者凝血酶激活的纤溶抑制物与纤维蛋白原关系分析